Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$6.71 - $11.83 $743,085 - $1.31 Million
-110,743 Reduced 75.96%
35,057 $235,000
Q2 2023

Aug 14, 2023

BUY
$11.12 - $22.2 $1.52 Million - $3.04 Million
136,782 Added 1516.77%
145,800 $1.67 Million
Q1 2023

May 15, 2023

SELL
$18.7 - $23.07 $625,346 - $771,483
-33,441 Reduced 78.76%
9,018 $181,000
Q4 2022

Feb 14, 2023

SELL
$18.12 - $27.32 $1.22 Million - $1.84 Million
-67,457 Reduced 61.37%
42,459 $962,000
Q3 2022

Nov 14, 2022

BUY
$16.98 - $25.54 $23,517 - $35,372
1,385 Added 1.28%
109,916 $2.06 Million
Q2 2022

Aug 15, 2022

BUY
$13.15 - $20.45 $362,755 - $564,133
27,586 Added 34.08%
108,531 $2.02 Million
Q1 2022

May 16, 2022

BUY
$14.54 - $21.5 $1.18 Million - $1.74 Million
80,945 New
80,945 $1.46 Million
Q4 2021

Feb 14, 2022

SELL
$20.24 - $36.01 $256,967 - $457,182
-12,696 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$20.24 - $36.01 $655,209 - $1.17 Million
-32,372 Reduced 71.83%
12,696 $263,000
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $1.13 Million - $1.66 Million
-43,494 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$26.01 - $38.22 $1.17 Million - $1.72 Million
45,068 New
45,068 $1.44 Million
Q2 2021

Aug 16, 2021

BUY
$29.97 - $37.17 $1.3 Million - $1.62 Million
43,494 New
43,494 $1.34 Million
Q4 2020

Feb 16, 2021

SELL
$35.35 - $50.67 $18,382 - $26,348
-520 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$35.98 - $47.66 $18,709 - $24,783
520 New
520 $19,000
Q2 2019

Aug 14, 2019

SELL
$52.76 - $82.19 $225,760 - $351,691
-4,279 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$27.39 - $68.41 $2.09 Million - $5.22 Million
-76,300 Reduced 94.69%
4,279 $255,000
Q4 2018

Feb 14, 2019

SELL
$22.8 - $33.93 $7.65 Million - $11.4 Million
-335,341 Reduced 80.63%
80,579 $2.32 Million
Q3 2018

Nov 14, 2018

BUY
$29.75 - $43.08 $4.75 Million - $6.88 Million
159,651 Added 62.3%
415,920 $15.1 Million
Q2 2018

Aug 14, 2018

BUY
$21.96 - $39.94 $5.63 Million - $10.2 Million
256,269 New
256,269 $9.69 Million
Q1 2018

May 15, 2018

SELL
$17.1 - $26.61 $390,871 - $608,251
-22,858 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$9.47 - $19.59 $216,465 - $447,788
22,858
22,858 $448,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $270M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.